Kayothera Inc.
- Biotech or pharma, therapeutic R&D
Redefining the retinoid pathway: Developing first-in-class inhibitors of retinoid synthesis for type 2 diabetes, obesity and cancer
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}